# Galbraith Laboratories Inc - Inspection Records

Source: https://www.globalkeysolutions.net/companies/galbraith-laboratories-inc/6a269a6c-2d54-487f-93d9-8939dc052c2d

> Inspection records and compliance data for Galbraith Laboratories Inc in Knoxville, Tennessee. Access full analysis and detailed observations.

---

## Details

- Name: Galbraith Laboratories Inc
- FEI Number: 1000112629
- City: Knoxville
- State: Tennessee
- Country Name: United States
- Address Line 1: 2323 Sycamore Dr
- Zip Code: 37921
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Galbraith Laboratories Inc - 2023-11-16](https://www.globalkeysolutions.net/records/483/galbraith-laboratories-inc/041a6eb6-c541-4c83-af78-47857aaa75c1) — source: FDA, date: November 16, 2023
- [FDA Inspection 1222900 - Galbraith Laboratories Inc - 2023-11-16](https://www.globalkeysolutions.net/records/fda_inspections/galbraith-laboratories-inc/4cadf4b4-0c80-4dd1-9c4f-9da73da15165) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 16, 2023
- [483 - Galbraith Laboratories Inc - 2022-03-02](https://www.globalkeysolutions.net/records/483/galbraith-laboratories-inc/67d2319b-7e82-4720-b800-0978b4a88632) — source: FDA, date: March 2, 2022
- [FDA Inspection 1163571 - Galbraith Laboratories Inc - 2022-03-02](https://www.globalkeysolutions.net/records/fda_inspections/galbraith-laboratories-inc/a135ac1d-f253-4053-9753-22f87960aefa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 2, 2022
- [FDA Inspection 993886 - Galbraith Laboratories Inc - 2016-12-01](https://www.globalkeysolutions.net/records/fda_inspections/galbraith-laboratories-inc/f6739a6e-073d-4a52-b558-401a88076de3) — classification: No Action Indicated (NAI), source: FDA, date: December 1, 2016
- [FDA Inspection 905657 - Galbraith Laboratories Inc - 2014-12-03](https://www.globalkeysolutions.net/records/fda_inspections/galbraith-laboratories-inc/93e2916a-3bd9-4af6-ae36-c75e5de3b8d4) — classification: No Action Indicated (NAI), source: FDA, date: December 3, 2014
- [FDA Inspection 867685 - Galbraith Laboratories Inc - 2014-02-11](https://www.globalkeysolutions.net/records/fda_inspections/galbraith-laboratories-inc/6bc680f2-5311-46ca-b6af-cb5a67d2017a) — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2014
- [FDA Inspection 867685 - Galbraith Laboratories Inc - 2014-02-11](https://www.globalkeysolutions.net/records/fda_inspections/galbraith-laboratories-inc/2f730bf0-53d6-4c82-b28e-9c8d6f085dd2) — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2014
- [FDA Inspection 714534 - Galbraith Laboratories Inc - 2011-03-09](https://www.globalkeysolutions.net/records/fda_inspections/galbraith-laboratories-inc/1e696414-e6c9-4691-ad9a-a65aabdb1a7c) — classification: No Action Indicated (NAI), source: FDA, date: March 9, 2011
- [FDA Inspection 681621 - Galbraith Laboratories Inc - 2010-09-07](https://www.globalkeysolutions.net/records/fda_inspections/galbraith-laboratories-inc/fcdb210d-adfd-453d-b530-4e2e6bb878c4) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2010

## Related Companies

- [Meridian Medical Technologies, LLC a Subsidiary of Kindeva Drug Delivery, L.P.](https://www.globalkeysolutions.net/companies/meridian-medical-technologies-llc-a-subsidiary-of-kindeva-drug-delivery-lp/00b844de-fb09-432d-96ab-31b8f7192a5d)
- [Astellas Pharma US Inc.](https://www.globalkeysolutions.net/companies/astellas-pharma-us-inc/3bb1b330-7226-4071-b93b-2854ea7577cb)
- [Charles River Laboratories Edinburgh Ltd.](https://www.globalkeysolutions.net/companies/charles-river-laboratories-edinburgh-ltd/54a33299-9310-47d8-a3b5-034723cd4094)
- [BrittonField Laboratories Inc.](https://www.globalkeysolutions.net/companies/brittonfield-laboratories-inc/1ef8d9f7-3e31-44d9-b3d9-c13a4751bcb2)
- [ChemWerth Pharmaceutical Technology (Shanghai) Co., LTD](https://www.globalkeysolutions.net/companies/chemwerth-pharmaceutical-technology-shanghai-co-ltd/bdd0edbf-bcaf-451b-ba0a-84c241db8655)
- [UFAG Laboratorien AG](https://www.globalkeysolutions.net/companies/ufag-laboratorien-ag/93342d96-9cf8-4c5f-9248-11d77990b790)
- [Chromak Research Inc](https://www.globalkeysolutions.net/companies/chromak-research-inc/e7eccd52-0e4f-4a4c-81e6-7331d2a64609)
- [Daicel Chiral Technologies (India) Private Limited](https://www.globalkeysolutions.net/companies/daicel-chiral-technologies-india-private-limited/45c91172-d6b1-4c1b-a405-8634d7314a7e)
- [Aptar France SAS](https://www.globalkeysolutions.net/companies/aptar-france-sas/b349dbdb-c2c3-43dc-9511-f887c9a99ae5)
- [Eurofins PROXY Laboratories B.V.](https://www.globalkeysolutions.net/companies/eurofins-proxy-laboratories-bv/f285c14e-3524-4cb3-8bd8-767736fdfa78)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/timothy-h-vo/08da7ca5-7f58-42bf-8046-e3a1bf879b48)
- [Pharmaceutical Specialist/ Investigator ](https://www.globalkeysolutions.net/people/veronica-fuentes/50ea657f-39e6-4d97-a627-86339df3fbe6)
- [Gretchen M. Laws](https://www.globalkeysolutions.net/people/gretchen-m-laws/9a3ecebd-099b-41d5-a2a7-70811a26cae1)
- [Investigator](https://www.globalkeysolutions.net/people/clinton-j-lott/ac4c7d18-13fd-4b1b-b2a1-06794c9960c7)